These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1078 related articles for article (PubMed ID: 24509937)

  • 21. Interplay between miRNAs and host genes and their role in cancer.
    Liu B; Shyr Y; Cai J; Liu Q
    Brief Funct Genomics; 2018 Jul; 18(4):255-266. PubMed ID: 30785618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implication of microRNAs in drug resistance for designing novel cancer therapy.
    Sarkar FH; Li Y; Wang Z; Kong D; Ali S
    Drug Resist Updat; 2010 Jun; 13(3):57-66. PubMed ID: 20236855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNAs: novel regulators in the hallmarks of human cancer.
    Ruan K; Fang X; Ouyang G
    Cancer Lett; 2009 Nov; 285(2):116-26. PubMed ID: 19464788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNAs targeting prostate cancer stem cells.
    Fang YX; Chang YL; Gao WQ
    Exp Biol Med (Maywood); 2015 Aug; 240(8):1071-8. PubMed ID: 25966983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of microRNA-338-3p in cancer: growth, invasion, chemoresistance, and mediators.
    Mirzaei S; Zarrabi A; Asnaf SE; Hashemi F; Zabolian A; Hushmandi K; Raei M; Goharrizi MASB; Makvandi P; Samarghandian S; Najafi M; Ashrafizadeh M; Aref AR; Hamblin MR
    Life Sci; 2021 Mar; 268():119005. PubMed ID: 33421526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR221/222 in cancer: their role in tumor progression and response to therapy.
    Garofalo M; Quintavalle C; Romano G; Croce CM; Condorelli G
    Curr Mol Med; 2012 Jan; 12(1):27-33. PubMed ID: 22082479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulating miRNA by natural agents as a new strategy for cancer treatment.
    Sethi S; Li Y; Sarkar FH
    Curr Drug Targets; 2013 Sep; 14(10):1167-74. PubMed ID: 23834152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?
    Gunaratne PH
    Curr Stem Cell Res Ther; 2009 Sep; 4(3):168-77. PubMed ID: 19492978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression profile of MicroRNA: An Emerging Hallmark of Cancer.
    Zaheer U; Faheem M; Qadri I; Begum N; Yassine HM; Al Thani AA; Mathew S
    Curr Pharm Des; 2019; 25(6):642-653. PubMed ID: 30914015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-221: biogenesis, function and signatures in human cancers.
    Abak A; Amini S; Sakhinia E; Abhari A
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3094-3117. PubMed ID: 29863255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy.
    Humphries B; Yang C
    Oncotarget; 2015 Mar; 6(9):6472-98. PubMed ID: 25762624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNAs in DNA Damage Response, Carcinogenesis, and Chemoresistance.
    Fang Y; Zhang L; Li Z; Li Y; Huang C; Lu X
    Int Rev Cell Mol Biol; 2017; 333():1-49. PubMed ID: 28729023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. microRNA: The Impact on Cancer Stemness and Therapeutic Resistance.
    Jiao X; Qian X; Wu L; Li B; Wang Y; Kong X; Xiong L
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer.
    Ward A; Shukla K; Balwierz A; Soons Z; König R; Sahin O; Wiemann S
    J Pathol; 2014 Aug; 233(4):368-79. PubMed ID: 24752803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-Mediated Post-Transcriptional Regulation of Epithelial to Mesenchymal Transition in Cancer.
    Behbahani GD; Ghahhari NM; Javidi MA; Molan AF; Feizi N; Babashah S
    Pathol Oncol Res; 2017 Jan; 23(1):1-12. PubMed ID: 27590333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metastamirs: a stepping stone towards improved cancer management.
    White NM; Fatoohi E; Metias M; Jung K; Stephan C; Yousef GM
    Nat Rev Clin Oncol; 2011 Feb; 8(2):75-84. PubMed ID: 21045789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unraveling the role of miRNAs in the diagnosis, progression, and drug resistance of oral cancer.
    Doghish AS; Elshaer SS; Fathi D; Rizk NI; Elrebehy MA; Al-Noshokaty TM; Elballal MS; Abdelmaksoud NM; Abdel-Reheim MA; Abdel Mageed SS; Zaki MB; Mohammed OA; Tabaa MME; Elballal AS; Saber S; El-Husseiny HM; Abulsoud AI
    Pathol Res Pract; 2024 Jan; 253():155027. PubMed ID: 38101159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-205: A Potential Biomedicine for Cancer Therapy.
    Chauhan N; Dhasmana A; Jaggi M; Chauhan SC; Yallapu MM
    Cells; 2020 Aug; 9(9):. PubMed ID: 32854238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EMT-associated microRNAs and their roles in cancer stemness and drug resistance.
    Pan G; Liu Y; Shang L; Zhou F; Yang S
    Cancer Commun (Lond); 2021 Mar; 41(3):199-217. PubMed ID: 33506604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNAs as Modulators of Oral Tumorigenesis-A Focused Review.
    Rishabh K; Khadilkar S; Kumar A; Kalra I; Kumar AP; Kunnumakkara AB
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33806361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.